[9] Meier, J.J., Butler, A.E., Saisho, Y., Monchamp, T., Galasso, R., Bhushan, A., et al. 2008. Beta-cell replication is the primary mechanism subserving the postnatal expansion of betacell mass in humans. Diabetes 57:1584-1594. [10] Chen, H., Gu, X., Liu, Y., Wang,...
[12] Gribble, F.M., Williams, L., Simpson, A.K., Reimann, F. 2003. A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 52:1147-1154. [13] ...
[28] Wang X, Zhou J, Doyle ME, Egan JM,2001. Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kina...
[12] Gribble, F.M., Williams, L., Simpson, A.K., Reimann, F. 2003. A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 52:1147-1154. [13] Sugiyama, K., Manaka, H., Kato, T., Yamatani, K., Tominaga, M., Sas...
[28] Wang, X., Zhou, J., Doyle, M.E., Egan, J.M. 2001. Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism. Endocrinology 142:...
[12] Gribble, F.M., Williams, L., Simpson, A.K., Reimann, F. 2003. A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 52:1147-1154. [13] Sugiyama, K., Manaka, H., Kato, T., Yamatani, K., Tominaga, M., Sas...
[76] Trevaskis, J.L., Mack, C.M., Sun, C., Soares, C.J., D'Souza, L.J., Levy, O.E., et al. 2013. Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybrids. PLoS One 8:e78154. ...
[48] Chai, W., Dong, Z., Wang, N., Wang, W., Tao, L., Cao, W., et al. 2012. Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxidedependent mechanism. Diabetes 61:888-896. ...
[76] Trevaskis, J.L., Mack, C.M., Sun, C., Soares, C.J., D'Souza, L.J., Levy, O.E., et al. 2013. Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybrids. PLoS One 8:e78154. ...
mechanism of actionsemaglutideWhat is known and objective: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are one of the preferred approved treatment options for people with type 2 diabetes (T2D) and inadequate glycaemic control. The objective of this review is to provide a general ...